Galapagos receives transparency notification from FMR LLC
03 Setembro 2024 - 5:01PM
UK Regulatory
Galapagos receives transparency notification from FMR LLC
Mechelen, Belgium; 3 September 2024, 22:01
CET; regulated information – Galapagos NV (Euronext & NASDAQ:
GLPG) received a transparency notification from FMR
LLC.
Pursuant to Belgian transparency
legislation1, Galapagos received a transparency
notification on 30 August 2024 from FMR LLC, who notified that it
holds 2,687,116 of Galapagos’ voting rights, consisting of
2,686,016 ordinary shares and 1,100 equivalent financial
instruments. FMR LLC controls investment funds Fidelity Management
& Research Company LLC, FIAM LLC, Fidelity Management Trust
Company, Strategic Advisers LLC, and FMR Investment Management (UK)
Limited, of which Fidelity Management & Research Company LLC
decreased its position to 2,469,688 voting rights and 1,100
equivalent financial instruments (stock loan), FIAM LLC decreased
its position to 119,198 voting rights, Fidelity Management Trust
Company decreased its position to 11,879 voting rights, Strategic
Advisers LLC maintained its position of 1 voting right, and FMR
Investment Management (UK) Limited maintained its position of
85,250 voting rights.
FMR LLC’s holding of 2,687,116 Galapagos’ voting
rights, including its controlled undertakings’ holdings, represents
4.08% of Galapagos’ currently outstanding 65,897,071 shares. FMR
LLC thus crossed below the 5% threshold of Galapagos’ voting
rights. The full transparency notice is available on the Galapagos
website.
About Galapagos
We are a biotechnology company with operations in Europe and the
U.S. dedicated to developing transformational medicines for more
years of life and quality of life. Focusing on high unmet medical
needs, we synergize compelling science, technology, and
collaborative approaches to create a deep pipeline of best-in-class
small molecules and cell therapies in oncology and immunology. With
capabilities from lab to patient, including a decentralized cell
therapy manufacturing network, we are committed to challenging the
status quo and delivering results for our patients, employees, and
shareholders. For additional information, please
visit www.glpg.com or follow us
on LinkedIn or X.
For further information, please
contact:
Media
inquiries:
Marieke Vermeersch
+32 479 490 603
media@glpg.com
Jennifer Wilson
+44 7444 896759
media@glpg.com |
Investor
inquiries:
Sofie Van Gijsel
+1 781 296 1143
ir@glpg.com
Sandra Cauwenberghs
+32 495 584 663
ir@glpg.com |
1 Belgian Act of 2 May 2007 on the
disclosure of major shareholdings in issuers whose shares are
admitted to trading on a regulated market.
- GLPG EN PR_FMR LLC 30 August 2024_ENG
Galapagos (EU:GLPG)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Galapagos (EU:GLPG)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024